Galera Therapeutics, Inc.
GRTX
$0.0215
$0.00010.47%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 54.72% | 64.66% | 67.91% | 71.85% | 58.80% |
| Total Depreciation and Amortization | -97.93% | -95.56% | -92.28% | 235.71% | 184.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.13% | -34.79% | -47.23% | -64.88% | -67.62% |
| Change in Net Operating Assets | 70.03% | 71.01% | 27.30% | -1,102.45% | -331.73% |
| Cash from Operations | 72.18% | 74.74% | 72.92% | 59.65% | 34.29% |
| Capital Expenditure | -- | -- | -- | 82.00% | 83.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -84.76% | -28.80% |
| Cash from Investing | -100.32% | -100.21% | -100.17% | -84.75% | -28.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -37.01% | -54.99% | -93.49% | -- | -85.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 200.00% | -- |
| Cash from Financing | 50.26% | -23.05% | -92.94% | -100.67% | -94.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 59.43% | 44.75% | -171.50% | -237.13% | -295.00% |